NCT07487168 2026-03-23
Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Not yet recruiting
Clinical Trials
13 trialsNCT04329494 2025-12-10
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
City of Hope Medical Center
Phase 1 Recruiting
NCT04046133 2025-08-05
CORINTH
Cardiff University
Phase 1 Active not recruiting
NCT04200417 2025-05-16
Chemoembolization for Lung Tumors
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT05979909 2023-08-07
Intravesical Mitomycin C After Diagnostic Ureteroscopy for Upper Tract Urothelial Carcinoma
McMaster University
Phase 1 Not yet recruiting
NCT03330028 2023-04-21
Study of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology
M.D. Anderson Cancer Center
Phase 1 Completed
NCT01621217 2020-02-28
NOAC8
Lund University Hospital
Phase 1 Completed
NCT00003003 2018-03-19
Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia
Dartmouth-Hitchcock Medical Center
Phase 1 Completed
NCT01011010 2018-01-05
Sorafenib Tosylate and Chemoembolization With Doxorubicin Hydrochloride and Mitomycin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
UNC Lineberger Comprehensive Cancer Center
Phase 1 Completed
NCT01296763 2016-03-22
Trial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT02311101 2015-12-03
Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer
The University of Texas Health Science Center at San Antonio
Phase 1 Completed
NCT01042041 2013-02-26
Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT00003710 2012-08-09
Irinotecan Plus Mitomycin in Treating Patients With Advanced Solid Tumors
The University of Texas Health Science Center at San Antonio
Phase 1 Completed